Global edition
Region
NewsCase StudiesWebcastsInterviewsEventsPodcastsMagazine
Sign inSubscribe
Follow Pharma Now@pharmanow.live
Editions & local coverage
United StatesUnited KingdomGermanyFranceItalyIndiaSwitzerlandSingapore

A global knowledge and leadership platform for pharma. We turn complexity into clarity professionals can act on.

Get the Pharma Now app

Read offline, save stories and never miss an edition.

Get it onGoogle PlayDownload on theApp Store
Verticals
  • Leadership
  • AI in Pharma
  • Manufacturing
  • Marketing
  • HR in Pharma
  • Microbiology & CCS
  • Regulatory Landscape
Formats
  • News & Analysis
  • Interviews
  • Case Studies
  • Webcasts
  • Podcasts
  • Events
  • Magazine
Knowledge Hub
  • Knowledge Hub
  • Research Papers
  • Buyer’s Guides
  • Companies
  • Newsletter Archive
  • Glossary
Company
  • Advisory Board
  • Contributors
  • Write for Us
  • Submit a PR
  • Contact
  • Advertise
Account
  • Subscribe
  • Sign in
  • My Account
  • Partner with us
Frequently asked

Pharma Now is a leading monthly B2B magazine focused on delivering in-depth content related to the pharmaceutical and biopharma sectors. It covers the latest trends, technological innovations, leadership insights, market developments, and interviews with industry experts.

Pharma Now provides comprehensive coverage, including: - Industry news and updates - Interviews with global pharma leaders - Market insights and trends - Innovations in AI, manufacturing, and pharma operations - Case studies, thought leadership articles, and regulatory updates

Pharma Now caters to a wide range of professionals within the pharmaceutical industry, including C-level executives, R&D professionals, quality managers, regulatory affairs specialists, and business leaders looking to stay informed about global trends and innovations.

You can subscribe to Pharma Now by visiting the Pharma Now website and choosing between print and digital editions.

Yes, Pharma Now welcomes contributions from industry experts. Contributors can submit articles, thought leadership pieces, and case studies. You can register on the contributors' page to submit content and gain recognition for your insights.

Pharma Now offers multiple advertising packages tailored to help companies promote their products, services, and innovations. From full-page ads to special event coverage, advertisers can reach a targeted audience of pharma professionals. For details, visit the Advertise With Us section on the website.

Copyright © 2026 Tantragyan Technologies Pvt Ltd. All Rights Reserved.
Privacy PolicyTerms of UseContact UsAdvertise
Companies/Fortcaps Healthcare Ltd
Fortcaps Healthcare Ltd

Fortcaps Healthcare Ltd

Pharmaceutical Manufacturing
API Production Machinery
Visit website ↗Contact
LinkedInFacebook

About Fortcaps Healthcare Ltd

Fortcaps Healthcare Ltd., a wholly owned subsidiary of Kumar Organic Products Limited (KOPL), is among the Top 5 capsule manufacturers in India, specializing in Empty Hard Gelatin (EHG) capsules and Pullulan vegetarian capsules (Satvik certified). Established in 1992, Fortcaps caters to the growing global demand for high-quality pharmaceutical capsules, offering precision, quality, and scalability.

Located in Madhya Pradesh, the company operates a state-of-the-art manufacturing plant with 16 fully automated capsule production lines, producing over 6.5 billion capsules annually. Fortcaps serves over 200 clients globally, exporting to several countries while ensuring regulatory compliance with GMP, USFDA, and Satvik certifications.

Backed by the expertise of KOPL, a leading specialty chemical manufacturer with four USFDA-inspected plants, Fortcaps delivers premium capsule solutions for the pharmaceutical, nutraceutical, and health supplement industries worldwide.

Company details
IndustryPharmaceutical Manufacturing
CategoryAPI Production Machinery
Head officeNo. 112, First Floor, Star Mall, Sector 30, NH-08, Gurugram- 122001, Haryana
ContactAnand Kashyap
Phone11 4560 0377
Emailakashyap@fortcaps.com
Websitefortcaps.com
The signal
The week in pharma, distilled

One considered email — the stories, moves and numbers that matter, every Friday.